Test Code ROMA1 Risk Score, if Premenopausal, Serum
Secondary ID
46916Method Name
Only orderable as part of a profile. For more information see ROMA / Ovarian Malignancy Risk Algorithm.
Calculation
Reporting Name
Risk Score, if premenopausalSpecimen Type
SerumSpecimen Required
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Frozen (preferred) | 84 days | |
Refrigerated | 48 hours |
Reference Values
Only orderable as part of a profile. For more information see ROMA / Ovarian Malignancy Risk Algorithm.
Premenopausal:<1.14 (low risk)
Performing Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
Not ApplicableLOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ROMA1 | Risk Score, if premenopausal | 69569-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
ROMA1 | Risk Score, if premenopausal | 69569-2 |
Useful For
Calculating risk assessment for finding an ovarian malignancy during surgery in premenopausal women who present with an adnexal mass
Clinical Information
Women with ovarian cancer symptoms and adnexal masses present primarily to gynecologists, primary care physicians, or general surgeons. Triage guidelines from the American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncologists recommend referral of women with a pelvic mass at high risk for ovarian cancer to gynecologic oncologists. Specialized treatment improves patient outcomes resulting in fewer complications and better survival rates when compared to patients treated by surgeons less familiar with the management of ovarian cancer.
The risk of ovarian malignancy algorithm (ROMA) incorporates cancer antigen 125 (CA125), human epididymal protein 4 (HE4), and menopausal status to assign women that present with an adnexal mass into a high-risk or low-risk group for finding an ovarian malignancy. ROMA is indicated for women who meet the following criteria: older than age 18, presenting with an adnexal mass for which surgery is planned, and who have not yet been referred to an oncologist. ROMA must be interpreted in conjunction with clinical and radiological assessment
Interpretation
In premenopausal women, a risk of ovarian malignancy algorithm (ROMA) value of 1.14 or greater indicates a high risk of finding epithelial ovarian cancer, whereas a ROMA value less than 1.14 indicates a low risk of finding epithelial ovarian cancer at surgery.
The use of these cutpoints provides a 75% specificity and sensitivity of 84% in patients with stage I-IV epithelial ovarian cancer.
Method Description
The risk score calculation is performed by the laboratory information system.
Day(s) Performed
Monday through Friday